Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma - a pilot prospective study.

Bagley S, Nabavizadeh SA, Mays J, Till JE, Ware J, Levy S, Sarchiapone W, Hussain J, Prior TJ, Guiry S, Christensen T, Yee SS, Nasrallah M, Morrissette JJ, Binder Z, O'Rourke DM, Cucchiara AJ, Brem S, Desai AS, Carpenter EL.

Clin Cancer Res. 2019 Oct 30. pii: clincanres.2533.2019. doi: 10.1158/1078-0432.CCR-19-2533. [Epub ahead of print]

PMID:
31666247
2.

Rare Event Phenotyping and Molecular Characterization: Circulating Tumor Cells.

Sen M, Wang L, Yu L, Carpenter EL.

Methods Mol Biol. 2019;2032:213-226. doi: 10.1007/978-1-4939-9650-6_13.

PMID:
31522422
3.

Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.

Sen M, Hahn F, Black TA, DeMarshall M, Porter W, Snowden E, Yee SS, Tong F, Ferguson M, Fleshman EN, Nakagawa H, Falk GW, Ginsberg GG, Kochman ML, Blaesius R, Rustgi AK, Carpenter EL.

Oncotarget. 2019 Aug 20;10(49):5119. doi: 10.18632/oncotarget.27161. eCollection 2019 Aug 20.

4.

Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.

Sen M, Hahn F, Black TA, DeMarshall M, Porter W, Snowden E, Yee SS, Tong F, Ferguson M, Fleshman EN, Nakagawa H, Falk GW, Ginsberg GG, Kochman ML, Blaesius R, Rustgi AK, Carpenter EL.

Oncotarget. 2019 Jun 4;10(38):3592-3604. doi: 10.18632/oncotarget.26911. eCollection 2019 Jun 4. Erratum in: Oncotarget. 2019 Aug 20;10(49):5119.

5.

Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAFV600E mutation bearing metastatic melanoma cells.

Carpenter EL, Chagani S, Nelson D, Cassidy PB, Laws M, Ganguli-Indra G, Indra AK.

Mol Carcinog. 2019 Sep;58(9):1680-1690. doi: 10.1002/mc.23068. Epub 2019 Jun 18.

PMID:
31211467
6.

A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.

Goos JAC, Vogel WK, Mlcochova H, Millard CJ, Esfandiari E, Selman WH, Calpena E, Koelling N, Carpenter EL, Swagemakers SMA, van der Spek PJ, Filtz TM, Schwabe JWR, Iwaniec UT, Mathijssen IMJ, Leid M, Twigg SRF.

Hum Mol Genet. 2019 Apr 3. pii: ddz072. doi: 10.1093/hmg/ddz072. [Epub ahead of print]

7.

Hepatocytes direct the formation of a pro-metastatic niche in the liver.

Lee JW, Stone ML, Porrett PM, Thomas SK, Komar CA, Li JH, Delman D, Graham K, Gladney WL, Hua X, Black TA, Chien AL, Majmundar KS, Thompson JC, Yee SS, O'Hara MH, Aggarwal C, Xin D, Shaked A, Gao M, Liu D, Borad MJ, Ramanathan RK, Carpenter EL, Ji A, de Beer MC, de Beer FC, Webb NR, Beatty GL.

Nature. 2019 Mar;567(7747):249-252. doi: 10.1038/s41586-019-1004-y. Epub 2019 Mar 6.

8.

Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.

Aggarwal C, Davis CW, Mick R, Thompson JC, Ahmed S, Jeffries S, Bagley S, Gabriel P, Evans TL, Bauml JM, Ciunci C, Alley E, Morrissette JJD, Cohen RB, Carpenter EL, Langer CJ.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00107. Epub 2018 Aug 31.

9.

Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.

Thompson JC, Fan R, Black T, Yu GH, Savitch SL, Chien A, Yee SS, Sen M, Hwang WT, Katz SI, Feldman M, Vachani A, Carpenter EL.

Lung Cancer. 2019 Jan;127:25-33. doi: 10.1016/j.lungcan.2018.11.020. Epub 2018 Nov 19.

10.

An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.

Yu L, Sa S, Wang L, Dulmage K, Bhagwat N, Yee SS, Sen M, Pletcher CH Jr, Moore JS, Saksena S, Dixon EP, Carpenter EL.

Cytometry A. 2018 Dec;93(12):1226-1233. doi: 10.1002/cyto.a.23599.

PMID:
30549400
11.

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.

Aggarwal C, Thompson JC, Black TA, Katz SI, Fan R, Yee SS, Chien AL, Evans TL, Bauml JM, Alley EW, Ciunci CA, Berman AT, Cohen RB, Lieberman DB, Majmundar KS, Savitch SL, Morrissette JJD, Hwang WT, Elenitoba-Johnson KSJ, Langer CJ, Carpenter EL.

JAMA Oncol. 2019 Feb 1;5(2):173-180. doi: 10.1001/jamaoncol.2018.4305.

12.

Photoprotective Properties of Isothiocyanate and Nitrile Glucosinolate Derivatives From Meadowfoam (Limnanthes alba) Against UVB Irradiation in Human Skin Equivalent.

Carpenter EL, Le MN, Miranda CL, Reed RL, Stevens JF, Indra AK, Ganguli-Indra G.

Front Pharmacol. 2018 May 15;9:477. doi: 10.3389/fphar.2018.00477. eCollection 2018.

13.

miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer.

Ko J, Bhagwat N, Black T, Yee SS, Na YJ, Fisher S, Kim J, Carpenter EL, Stanger BZ, Issadore D.

Cancer Res. 2018 Jul 1;78(13):3688-3697. doi: 10.1158/0008-5472.CAN-17-3703. Epub 2018 May 7.

14.

An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters.

Bhagwat N, Dulmage K, Pletcher CH Jr, Wang L, DeMuth W, Sen M, Balli D, Yee SS, Sa S, Tong F, Yu L, Moore JS, Stanger BZ, Dixon EP, Carpenter EL.

Sci Rep. 2018 Mar 22;8(1):5035. doi: 10.1038/s41598-018-23217-5.

15.

Asymmetric Synthesis and Biological Activities of Pactamycin-Inspired Aminocyclopentitols.

Brumsted CJ, Carpenter EL, Indra AK, Mahmud T.

Org Lett. 2018 Jan 19;20(2):397-400. doi: 10.1021/acs.orglett.7b03681. Epub 2018 Jan 10.

PMID:
29319326
16.

Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.

Chagani S, Wang R, Carpenter EL, Löhr CV, Ganguli-Indra G, Indra AK.

BMC Cancer. 2017 Nov 9;17(1):736. doi: 10.1186/s12885-017-3714-6.

17.

Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes.

Ko J, Bhagwat N, Yee SS, Ortiz N, Sahmoud A, Black T, Aiello NM, McKenzie L, O'Hara M, Redlinger C, Romeo J, Carpenter EL, Stanger BZ, Issadore D.

ACS Nano. 2017 Nov 28;11(11):11182-11193. doi: 10.1021/acsnano.7b05503. Epub 2017 Oct 17.

PMID:
29019651
18.

Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.

Yee SS, Carpenter EL.

Methods Mol Biol. 2017;1634:193-202. doi: 10.1007/978-1-4939-7144-2_16.

PMID:
28819852
19.

A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysis.

Ko J, Bhagwat N, Yee SS, Black T, Redlinger C, Romeo J, O'Hara M, Raj A, Carpenter EL, Stanger BZ, Issadore D.

Lab Chip. 2017 Sep 12;17(18):3086-3096. doi: 10.1039/c7lc00703e.

20.

Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.

Gangadhar TC, Savitch SL, Yee SS, Xu W, Huang AC, Harmon S, Lieberman DB, Soucier D, Fan R, Black TA, Morrissette JJD, Salathia N, Waters J, Zhang S, Toung J, van Hummelen P, Fan JB, Xu X, Amaravadi RK, Schuchter LM, Karakousis GC, Hwang WT, Carpenter EL.

Pigment Cell Melanoma Res. 2018 Jan;31(1):73-81. doi: 10.1111/pcmr.12623. Epub 2017 Oct 23.

21.

Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis.

Bhagwat N, Carpenter EL.

Adv Exp Med Biol. 2017;994:105-118. doi: 10.1007/978-3-319-55947-6_5. Review.

PMID:
28560670
22.

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.

Thompson JC, Yee SS, Troxel AB, Savitch SL, Fan R, Balli D, Lieberman DB, Morrissette JD, Evans TL, Bauml J, Aggarwal C, Kosteva JA, Alley E, Ciunci C, Cohen RB, Bagley S, Stonehouse-Lee S, Sherry VE, Gilbert E, Langer C, Vachani A, Carpenter EL.

Clin Cancer Res. 2016 Dec 1;22(23):5772-5782. Epub 2016 Sep 6.

23.

A novel approach for next-generation sequencing of circulating tumor cells.

Yee SS, Lieberman DB, Blanchard T, Rader J, Zhao J, Troxel AB, DeSloover D, Fox AJ, Daber RD, Kakrecha B, Sukhadia S, Belka GK, DeMichele AM, Chodosh LA, Morrissette JJ, Carpenter EL.

Mol Genet Genomic Med. 2016 Feb 28;4(4):395-406. doi: 10.1002/mgg3.210. eCollection 2016 Jul.

24.

Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.

Xu MJ, Dorsey JF, Amaravadi R, Karakousis G, Simone CB 2nd, Xu X, Xu W, Carpenter EL, Schuchter L, Kao GD.

Oncologist. 2016 Jan;21(1):84-94. doi: 10.1634/theoncologist.2015-0207. Epub 2015 Nov 27. Review.

25.

Skeletal Muscle in Healthy Subjects versus Those with GNE-Related Myopathy: Evaluation with Shear-Wave US--A Pilot Study.

Carpenter EL, Lau HA, Kolodny EH, Adler RS.

Radiology. 2015 Nov;277(2):546-54. doi: 10.1148/radiol.2015142212. Epub 2015 Jun 2.

PMID:
26035587
26.

Focus on advanced magnetic resonance techniques in clinical practice: magnetic resonance neurography.

Carpenter EL, Bencardino JT.

Radiol Clin North Am. 2015 May;53(3):513-29. doi: 10.1016/j.rcl.2014.12.002. Epub 2015 Jan 30.

PMID:
25953287
27.

Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells.

Carpenter EL, Rader J, Ruden J, Rappaport EF, Hunter KN, Hallberg PL, Krytska K, O'Dwyer PJ, Mosse YP.

Front Oncol. 2014 Jul 31;4:201. doi: 10.3389/fonc.2014.00201. eCollection 2014.

28.

Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Rader J, Russell MR, Hart LS, Nakazawa MS, Belcastro LT, Martinez D, Li Y, Carpenter EL, Attiyeh EF, Diskin SJ, Kim S, Parasuraman S, Caponigro G, Schnepp RW, Wood AC, Pawel B, Cole KA, Maris JM.

Clin Cancer Res. 2013 Nov 15;19(22):6173-82. doi: 10.1158/1078-0432.CCR-13-1675. Epub 2013 Sep 17.

29.

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.

Diskin SJ, Capasso M, Schnepp RW, Cole KA, Attiyeh EF, Hou C, Diamond M, Carpenter EL, Winter C, Lee H, Jagannathan J, Latorre V, Iolascon A, Hakonarson H, Devoto M, Maris JM.

Nat Genet. 2012 Oct;44(10):1126-30. doi: 10.1038/ng.2387. Epub 2012 Sep 2.

30.

Targeting ALK in neuroblastoma--preclinical and clinical advancements.

Carpenter EL, Mossé YP.

Nat Rev Clin Oncol. 2012 May 15;9(7):391-9. doi: 10.1038/nrclinonc.2012.72. Review.

31.

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.

Carpenter EL, Haglund EA, Mace EM, Deng D, Martinez D, Wood AC, Chow AK, Weiser DA, Belcastro LT, Winter C, Bresler SC, Vigny M, Mazot P, Asgharzadeh S, Seeger RC, Zhao H, Guo R, Christensen JG, Orange JS, Pawel BR, Lemmon MA, Mossé YP.

Oncogene. 2012 Nov 15;31(46):4859-67. doi: 10.1038/onc.2011.647. Epub 2012 Jan 23. Erratum in: Oncogene. 2012 Nov 15;31(46):4888. Vigny, M [added]; Mazot, P [added].

32.

Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

Bresler SC, Wood AC, Haglund EA, Courtright J, Belcastro LT, Plegaria JS, Cole K, Toporovskaya Y, Zhao H, Carpenter EL, Christensen JG, Maris JM, Lemmon MA, Mossé YP.

Sci Transl Med. 2011 Nov 9;3(108):108ra114. doi: 10.1126/scitranslmed.3002950.

33.

Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.

Carpenter EL, Mick R, Rüter J, Vonderheide RH.

J Transl Med. 2009 Nov 11;7:93. doi: 10.1186/1479-5876-7-93.

34.

Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers.

Carpenter EL, Mick R, Rech AJ, Beatty GL, Colligon TA, Rosenfeld MR, Kaplan DE, Chang KM, Domchek SM, Kanetsky PA, Fecher LA, Flaherty KT, Schuchter LM, Vonderheide RH.

Clin Cancer Res. 2009 Jul 1;15(13):4277-87. doi: 10.1158/1078-0432.CCR-09-0537. Epub 2009 Jun 23.

35.

Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration.

Carpenter EL, Vance BA, Klein RS, Voloschin A, Dalmau J, Vonderheide RH.

J Neuroimmunol. 2008 Jan;193(1-2):173-82. Epub 2007 Nov 28.

PMID:
18053582
36.

Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance.

Domchek SM, Recio A, Mick R, Clark CE, Carpenter EL, Fox KR, DeMichele A, Schuchter LM, Leibowitz MS, Wexler MH, Vance BA, Beatty GL, Veloso E, Feldman MD, Vonderheide RH.

Cancer Res. 2007 Nov 1;67(21):10546-55.

37.

Telomerase-based immunotherapy of cancer.

Carpenter EL, Vonderheide RH.

Expert Opin Biol Ther. 2006 Oct;6(10):1031-9. Review.

PMID:
16989585

Supplemental Content

Loading ...
Support Center